Lord, Abbett & Co’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-827,577
| Closed | -$38.9M | – | 576 |
|
2023
Q2 | $38.9M | Buy |
827,577
+637,244
| +335% | +$30M | 0.13% | 222 |
|
2023
Q1 | $7.99M | Buy |
+190,333
| New | +$7.99M | 0.03% | 429 |
|
2019
Q4 | – | Sell |
-221,994
| Closed | -$31.1M | – | 733 |
|
2019
Q3 | $31.1M | Sell |
221,994
-256,617
| -54% | -$36M | 0.11% | 317 |
|
2019
Q2 | $87.6M | Sell |
478,611
-142,057
| -23% | -$26M | 0.28% | 95 |
|
2019
Q1 | $98.7M | Buy |
620,668
+492,910
| +386% | +$78.4M | 0.33% | 71 |
|
2018
Q4 | $12.2M | Sell |
127,758
-172,807
| -57% | -$16.6M | 0.04% | 498 |
|
2018
Q3 | $42.5M | Sell |
300,565
-240,313
| -44% | -$33.9M | 0.12% | 289 |
|
2018
Q2 | $84.7M | Buy |
540,878
+73,024
| +16% | +$11.4M | 0.25% | 114 |
|
2018
Q1 | $75.4M | Sell |
467,854
-203,681
| -30% | -$32.8M | 0.22% | 122 |
|
2017
Q4 | $111M | Buy |
671,535
+395,870
| +144% | +$65.2M | 0.31% | 68 |
|
2017
Q3 | $17.2M | Sell |
275,665
-86,023
| -24% | -$5.36M | 0.05% | 513 |
|
2017
Q2 | $28.8M | Sell |
361,688
-332,818
| -48% | -$26.5M | 0.09% | 354 |
|
2017
Q1 | $49.4M | Buy |
694,506
+121,452
| +21% | +$8.63M | 0.15% | 214 |
|
2016
Q4 | $29.3M | Sell |
573,054
-105,994
| -16% | -$5.41M | 0.09% | 322 |
|
2016
Q3 | $31.3M | Sell |
679,048
-43,752
| -6% | -$2.01M | 0.1% | 335 |
|
2016
Q2 | $21.8M | Buy |
722,800
+191,396
| +36% | +$5.77M | 0.07% | 395 |
|
2016
Q1 | $17M | Sell |
531,404
-563,879
| -51% | -$18.1M | 0.05% | 453 |
|
2015
Q4 | $63.9M | Buy |
1,095,283
+834,915
| +321% | +$48.7M | 0.19% | 145 |
|
2015
Q3 | $11M | Sell |
260,368
-826,741
| -76% | -$35M | 0.03% | 563 |
|
2015
Q2 | $79.4M | Buy |
1,087,109
+907,212
| +504% | +$66.2M | 0.21% | 125 |
|
2015
Q1 | $9.04M | Buy |
179,897
+71,671
| +66% | +$3.6M | 0.02% | 645 |
|
2014
Q4 | $3.96M | Buy |
+108,226
| New | +$3.96M | 0.01% | 774 |
|